The startup specializes in processing and analyzing autologous adipose-derived stem cells from patients' fat, providing services that include sterility testing, endotoxin assessment, and cell identity verification. This enables physicians to develop clinical protocols for treating osteoarthritis in compliance with FDA regulations.
Funding
$2.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many individuals face the potential for future health challenges and seek proactive measures to safeguard their well-being. Current regenerative medicine options often lack personalized approaches and long-term preservation strategies.
Solution
Personalized Stem Cells (PSC) provides autologous adipose-derived stem cell banking and processing services, offering individuals a way to secure their own cells for potential future use in regenerative medicine. PSC extracts, processes, and cryopreserves mesenchymal stem cells (MSCs) from a patient's fat tissue, storing them for potential therapeutic applications. The company offers two primary service options: StemPreserve™ for long-term storage and StemReady™ for cells prepared for near-term treatment. PSC adheres to strict FDA guidelines and conducts comprehensive safety testing to ensure the quality and viability of the stored stem cells.
Target Audience
PSC's primary customers are individuals seeking proactive health management through stem cell banking, as well as physicians looking to offer personalized regenerative medicine options to their patients.
Features
- Adipose-derived stem cell (ASC) extraction and processing in an FDA-inspected lab
- Two service options: StemPreserve™ (cryopreservation for future use) and StemReady™ (cells expanded and tested for near-term use)
- Proprietary cell culture and expansion technology to increase cell quantity
- Comprehensive safety testing, including sterility, endotoxin, and mycoplasma testing
- Cryopreservation in state-of-the-art tanks at ultra-low temperatures
- Clinical trials are underway, with a focus on knee osteoarthritis
- GMP-compliant manufacturing processes